{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:26:03Z","timestamp":1787646363031,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cca.2026.120888","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:34:19Z","timestamp":1770942859000},"page":"120888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Testing brigatinib in an oncological patient's hair: Evaluation of the time of disappearance after discontinuation and interpretation of concentrations obtained in regrowing hair after total loss"],"prefix":"10.1016","volume":"585","author":[{"given":"Nadia","family":"Arbouche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Traenkl\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-S\u00e9bastien","family":"Raul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Kintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cca.2026.120888_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2019.03.005","article-title":"Brigatinib: new-generation ALK inhibitor for nonsmall cell lung cancer","volume":"43","author":"Umbela","year":"2019","journal-title":"Curr. Probl. Cancer"},{"issue":"5","key":"10.1016\/j.cca.2026.120888_bb0010","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1007\/s10637-021-01095-5","article-title":"Effect of severe renal impairment on the pharmacokinetics of brigatinib","volume":"39","author":"Gupta","year":"2021","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.cca.2026.120888_bb0015","article-title":"Simultaneous quantification of brigatinib and brigatinib-analog in rat plasma and brain homogenate by LC-MS\/MS: application to comparative pharmacokinetic and brain distribution studies","author":"Li","year":"2019","journal-title":"Int. J. Anal. Chem."},{"key":"10.1016\/j.cca.2026.120888_bb0020","series-title":"Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers","year":"2020"},{"key":"10.1016\/j.cca.2026.120888_bb0025","series-title":"Perspectives and Challenges of Hair Analysis","first-page":"1","article-title":"Anatomy and Biology of hair at different ages","author":"Pelissier-Alicot","year":"2024"},{"key":"10.1016\/j.cca.2026.120888_bb0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpba.2019.04.031","article-title":"Quantification of the tyrosinase kinase inhibitor erlotinib in human scalp hair by liquid chromatography-tandem mass spectrometry: pitfalls for clinical application","volume":"172","author":"Braal","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.cca.2026.120888_bb0035","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jpba.2015.06.018","article-title":"Development and validation of an UPLC-MS\/MS method for the quantification of tamoxifen and is main metabolites in human scalp hair","volume":"114","author":"Drooger","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.cca.2026.120888_bb0040","first-page":"1","article-title":"Help for validation of analytical procedures in toxicology and therapeutic drug monitoring","volume":"17","author":"Digeon","year":"2005","journal-title":"Ann. Toxicol. Anal."},{"key":"10.1016\/j.cca.2026.120888_bb0045","series-title":"Hair analysis in clinical and forensic toxicology","first-page":"7","article-title":"Anatomy and Physiology of Hair, and Principles for its Collection","author":"Cooper","year":"2015"},{"issue":"14","key":"10.1016\/j.cca.2026.120888_bb0050","article-title":"Chemotherapy-induced hair loss: the use of biomarkers for predicting alopecic severity and treatment efficacy","volume":"17","author":"Haslam","year":"2019","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.cca.2026.120888_bb0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02432122","article-title":"A discourse on human hair fibers and reflections on the conservation of drug molecules","volume":"108","author":"P\u04e7tsch","year":"1996","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.cca.2026.120888_bb0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.forsciint.2017.11.004","article-title":"Role of hair pigmentation in drug incorporation into hair","volume":"281","author":"Yu","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.cca.2026.120888_bb0065","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00007691-199508000-00158","article-title":"Relationship between methadone dose, hair methadone concentration and hair color in man","volume":"17","author":"Wilson","year":"1995","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.cca.2026.120888_bb0070","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00493470","article-title":"Human scalp hair as evidence of individual dosage history of haloperidol: a possible linkage of haloperidol excretion into hair with hair pigment","volume":"282","author":"Uematso","year":"1990","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.cca.2026.120888_bb0075","article-title":"Advances in testing for sample manipulation in clinical and forensic toxicology\u2014part B: hair samples","author":"Wissenbach","year":"2023","journal-title":"Anal. Bioanal. Chem."},{"issue":"3","key":"10.1016\/j.cca.2026.120888_bb0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s004140050056","article-title":"Infuence of the cosmetic treatment of hair on drug testing","volume":"110","author":"Jurado","year":"1997","journal-title":"Int. J. Legal Med."},{"issue":"9","key":"10.1016\/j.cca.2026.120888_bb0085","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/dta.3404","article-title":"Incorporation of doxylamine and N-doxylamine-oxide in human hair and the impact of a permanent oxidative hair dye","volume":"15","author":"Ramirez Fernandez","year":"2023","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.cca.2026.120888_bb0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0379-0738(99)00152-8","article-title":"Influence of bleaching on stability of benzodiazepines in hair","volume":"107","author":"Yegles","year":"2000","journal-title":"Forensic Sci.Int."},{"issue":"9","key":"10.1016\/j.cca.2026.120888_bb0095","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/dta.2866","article-title":"Development of a new GC-MS\/MS method for the determination of metformin in human hair","volume":"12","author":"Arbouche","year":"2020","journal-title":"Drug Test Anal."},{"issue":"1","key":"10.1016\/j.cca.2026.120888_bb0100","first-page":"65","article-title":"Disappearance of tramadol and THC-COOH in hair after discontinuation of abuse. Two Different Profiles","volume":"44","author":"Kintz","year":"2020","journal-title":"J. Anal. Toxicol."},{"issue":"7","key":"10.1016\/j.cca.2026.120888_bb0105","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jat\/bkab101","article-title":"Promazine detection in human hair: presentation of an LC\u2013MS-MS method and pattern of drug discontinuation","volume":"46","author":"Kintz","year":"2022","journal-title":"J. Anal. Toxicol."},{"issue":"9","key":"10.1016\/j.cca.2026.120888_bb0110","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/dta.3444","article-title":"The duration of ketamine detection in hair after treatment cessation: case study and review of the literature in forensic and clinical casework","volume":"15","author":"Larabi","year":"2023","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.cca.2026.120888_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1373\/jalm.2017.025346","article-title":"Accurate estimation of drug intake day by microsegmental analysis of a strand of hair using internal temporal markers","volume":"3","author":"Kuwayama","year":"2018","journal-title":"J Appl Lab Med."},{"key":"10.1016\/j.cca.2026.120888_bb0120","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/dta.2997","article-title":"Single hair analysis: validation of a screening method for over 150 analytes and application on documented single-dose cases","volume":"13","author":"Wiedfeld","year":"2021","journal-title":"Drug Test Anal."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126000707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126000707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:58:43Z","timestamp":1787644723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126000707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":24,"alternative-id":["S0009898126000707"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.120888","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testing brigatinib in an oncological patient's hair: Evaluation of the time of disappearance after discontinuation and interpretation of concentrations obtained in regrowing hair after total loss","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.120888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120888"}}